Literature DB >> 9031581

Obstetric complications in autism: consequences or causes of the condition?

P F Bolton1, M Murphy, H Macdonald, B Whitlock, A Pickles, M Rutter.   

Abstract

OBJECTIVE: To determine whether and why obstetric complications are associated with autism.
METHOD: Obstetric histories, obtained at maternal interview and coded as an optimality score (OS), were compared in two groups: 78 families containing an autistic proband (ICD-10 criteria) and 27 families containing a down syndrome (DS) proband. The OS was examined in relation to offspring diagnosis, proband characteristics, and familial loading for autism and its phenotypic variants.
RESULTS: Autistic and DS probands had a significantly elevated OS compared with unaffected siblings, regardless of birth order position. The elevation was mainly due to an increase in mild as opposed to severe obstetric adversities. In autistic probands, the OS was best predicted by familial loading for autism and its phenotypic variants, but in the absence of this measure by the number of autistic symptoms. Among siblings of autistic probands affected with autism or its variants, the OS was best predicted by the probands' OS, and in its absence, by the measure of familial loading. In DS probands and siblings the OS was associated with increased maternal age, although this did not account for the OS elevation in DS probands.
CONCLUSIONS: Rather than playing any principal etiological role, the obstetric adversities associated with autism either represent an epiphenomenon of the condition or derive from some shared risk factor(s).

Entities:  

Mesh:

Year:  1997        PMID: 9031581     DOI: 10.1097/00004583-199702000-00018

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  34 in total

Review 1.  Genetic studies of autism: from the 1970s into the millennium.

Authors:  M Rutter
Journal:  J Abnorm Child Psychol       Date:  2000-02

2.  The role of prenatal, obstetric and neonatal factors in the development of autism.

Authors:  Linda Dodds; Deshayne B Fell; Sarah Shea; B Anthony Armson; Alexander C Allen; Susan Bryson
Journal:  J Autism Dev Disord       Date:  2011-07

Review 3.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

4.  A family genetic study of autism associated with profound mental retardation.

Authors:  E Starr; S K Berument; A Pickles; M Tomlins; A Bailey; K Papanikolaou; M Rutter
Journal:  J Autism Dev Disord       Date:  2001-02

Review 5.  Perinatal risk factors for schizophrenia: how specific are they?

Authors:  Hélène Verdoux
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 6.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

Review 7.  Prenatal risk factors for autism: comprehensive meta-analysis.

Authors:  Hannah Gardener; Donna Spiegelman; Stephen L Buka
Journal:  Br J Psychiatry       Date:  2009-07       Impact factor: 9.319

Review 8.  Genetics of autism: overview and new directions.

Authors:  P Szatmari; M B Jones; L Zwaigenbaum; J E MacLean
Journal:  J Autism Dev Disord       Date:  1998-10

Review 9.  Autism: in search of susceptibility genes.

Authors:  Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

10.  Positive screening for autism in ex-preterm infants: prevalence and risk factors.

Authors:  Catherine Limperopoulos; Haim Bassan; Nancy R Sullivan; Janet S Soul; Richard L Robertson; Marianne Moore; Steven A Ringer; Joseph J Volpe; Adré J du Plessis
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.